Brief: Lipocine Announces Strategic Realignment And Forward Focus On Treating CNS Disorders

Lipocine

26/09/2022 13:03

Sept 26 (Reuters) - Lipocine Inc  LPCN.O :
    * LIPOCINE ANNOUNCES STRATEGIC REALIGNMENT AND FORWARD FOCUS
ON
TREATING CNS DISORDERS
    * LIPOCINE INC SAYS CO TO EXPLORE STRATEGIC PARTNERSHIPS AND
OTHER
OPPORTUNITIES FOR NON-CORE ASSETS
    * LIPOCINE INC SAYS HAD $37.4 MILLION OF UNRESTRICTED CASH,
CASH
EQUIVALENTS AND MARKETABLE INVESTMENT SECURITIES, AS OF JUNE 30
    * LIPOCINE INC SAYS BELIEVES CASH WILL BE SUFFICIENT TO
SUPPORT
OPERATIONS AND CAPITAL EXPENDITURE UNTIL AT LEAST SEPTEMBER 30,
2023

Source text for Eikon:  ID:nPnb7yrh1a 
Further company coverage:  LPCN.O 
 ((Reuters.Briefs@thomsonreuters.com;;))